Dr Hubert Lochard, R&D Project Manager, will give a conference at Dissolution Testing, Bioavailability & Bioequivalence organised by Informa on November, 21st in Berlin.

The topic of his presentation is Bioavailability Enhancement by a Supercritical Process. He will give a better understanding of the challenges of developing poorly-soluble APIs, assessing the merits and limitations of nanopowders(particle design) and setting-up and conducting bioavailability studies.

Pierre Fabre Medicament – active ingredient division – will be participating to the following events:

• CPhI, Milan, September, 2nd – 4th
• AAPS, San Diego, CA, November, 12th -15th

For more information about Pierre Fabre Medicament – active ingredient division, please visit our web site or click on the link below.